NOBELPHARMA CONNECT

Serial Number 97655075
Registration 7302992
700

Registration Progress

Application Filed
Oct 31, 2022
Under Examination
Approved for Publication
Nov 28, 2023
Published for Opposition
Nov 28, 2023
Registered
Feb 13, 2024

Trademark Image

NOBELPHARMA CONNECT

Basic Information

Serial Number
97655075
Registration Number
7302992
Filing Date
October 31, 2022
Registration Date
February 13, 2024
Published for Opposition
November 28, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 13, 2024
Registration
Registered
Classes
035 036

Rights Holder

Nobelpharma Co., Ltd.

99
Address
1-17-24, Shinkawa, Chuo-ku
Tokyo 104-0033
JP

Ownership History

Nobelpharma Co., Ltd.

Original Applicant
99
Tokyo JP

Nobelpharma Co., Ltd.

Owner at Publication
99
Tokyo JP

Nobelpharma Co., Ltd.

Original Registrant
99
Tokyo JP

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Deadline
1572 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-02-13)
Due Date
February 13, 2030
Grace Period Ends
August 13, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Feb 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 28, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 28, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 8, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 24, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 20, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 31, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 31, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 31, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 23, 2023 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jan 21, 2023 ALIE A ASSIGNED TO LIE Loading...
Nov 21, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Nov 17, 2022 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business administration of patient reimbursement programs; business administration of pharmacy reimbursement programs and services; prior authorization facilitation, also known as healthcare cost containment services, namely, providing expedited review, processing and follow-up of prior authorization requests initiated by physicians' offices and pharmacies; pharmacy referral services provided via a global computer network
First Use Anywhere: Aug 31, 2022
First Use in Commerce: Aug 31, 2022
Class 036
Providing insurance and insurance reimbursement information; financial administration of patient reimbursement programs, namely, copay financial assistance programs; financial administration of pharmacy reimbursement programs and services; providing patient support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing information on insurance authorization forms, appeals and status, providing information on insurance-approved site-of-care facilities, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims; patient support program, namely, providing information about eligibility for financial assistance provided through patient benefits programs; providing consulting in the field of healthcare insurance benefits; healthcare insurance services, namely, benefit verification services
First Use Anywhere: Aug 31, 2022
First Use in Commerce: Aug 31, 2022

Additional Information

Design Mark
The mark consists of the stylized words "NOBELPHARMA" in black and "CONNECT" in blue underneath with a miscellaneous design consisting of four bars in blue and four dots in black.
Color Claim
The color(s) black and blue is/are claimed as a feature of the mark.
Pseudo Mark
NOBEL PHARMA CONNECT

Classification

International Classes
035 036